Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

deal   tags : Cancer    save search

Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
CANF | $1.99 1.02% -0.5% 7.8K twitter stocktwits trandingview |
Health Technology
| | O: 5.24% H: 2.71% C: -4.75%

cancer pancreatic deal
Lewis Brisbois, Weil Guide $335M Cancer Biotech SPAC Deal – Law360
Published: 2023-01-09 (Crawled : 00:00) - spacfeed.com
LTUM | News | $0.0364 33.16% 230K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: -7.5% H: 27.76% C: 7.0%

biotech deal cancer spac
Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab
Published: 2022-08-17 (Crawled : 14:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 0.95% C: 0.01%
IMAB | $1.81 0.56% 0.55% 340K twitter stocktwits trandingview |
Health Technology
| | O: -4.39% H: 0.52% C: -10.37%

aml trial cancer
Global Cancer Monoclonal Antibody Partnering Deal Terms and Agreements Report/Database 2022
Published: 2022-06-15 (Crawled : 11:00) - prnewswire.com
IMAB | $1.81 0.56% 0.55% 340K twitter stocktwits trandingview |
Health Technology
| | O: 3.17% H: 9.89% C: 7.58%

antibody deal cancer
Argenx Regains Rights to Blood Cancer Drug Following Dropped $1.6 Billion Deal
Published: 2021-06-08 (Crawled : 13:15) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 0.23% C: -1.14%

blood drop cancer drug
Geneseeq Inks Deal with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS Kit in China
Published: 2021-03-16 (Crawled : 20:00) - biospace.com/
ILMN | $117.43 0.63% 0.63% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 1.06% C: -0.36%

china cancer commercialization diagnostic in vitro
Nektar Secures Collaborative Deal with SFJ to Advance Head and Neck Cancer Therapy
Published: 2021-02-17 (Crawled : 20:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 11.31% H: 7.0% C: 1.84%

therapy cancer collaboration
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.